BDBM354189 1-(2-((2S,4R)-4-fluoro- 2-(4-fluoro-3-(6,7,8,9- tetrahydro-5H- [1,2,4]triazolo[4,3- a]azepin-3- yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 91::US9796741, cmp No. 91

SMILES NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(cc12)-c1ccnnc1

InChI Key InChIKey=LAUIADBXSLVZKN-IBVKSMDESA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 354189   

TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM354189(1-(2-((2S,4R)-4-fluoro- 2-(4-fluoro-3-(6,7,8,9- te...)
Affinity DataIC50: >1.00E+4nMAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent